Dynamic Technology Lab Private Ltd Acquires Shares of 1,310 Cigna Group $CI

Key Points

• Dynamic Technology Lab Private Ltd has acquired a stake in Cigna Group, purchasing 1,310 shares valued at approximately $431,000 in the first quarter.
• Cigna Group reported earnings of $7.20 EPS for the quarter, exceeding expectations, with revenue reaching $67.13 billion—an 11% increase year-over-year.
• The company declared a quarterly dividend of $1.51, reflecting a yield of 2.0%, with the ex-dividend date set for September 4th.

Dynamic Technology Lab Private Ltd bought a new position in shares of Cigna Group (NYSE:CI - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,310 shares of the health services provider's stock, valued at approximately $431,000.

A number of other large investors also recently modified their holdings of the stock. Family Legacy Inc. lifted its position in shares of Cigna Group by 0.5% during the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider's stock worth $2,138,000 after purchasing an additional 31 shares in the last quarter. Impact Investors Inc raised its stake in shares of Cigna Group by 1.6% during the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider's stock worth $650,000 after buying an additional 31 shares during the last quarter. Mission Wealth Management LP raised its stake in shares of Cigna Group by 1.5% during the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider's stock worth $691,000 after buying an additional 32 shares during the last quarter. Westend Capital Management LLC raised its stake in shares of Cigna Group by 8.1% during the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider's stock worth $140,000 after buying an additional 32 shares during the last quarter. Finally, Moody National Bank Trust Division raised its stake in shares of Cigna Group by 0.7% during the first quarter. Moody National Bank Trust Division now owns 4,587 shares of the health services provider's stock worth $1,509,000 after buying an additional 34 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently weighed in on CI. Wells Fargo & Company dropped their price target on shares of Cigna Group from $341.00 to $340.00 and set an "equal weight" rating for the company in a research note on Thursday, August 14th. Truist Financial set a $375.00 target price on shares of Cigna Group in a research note on Tuesday, September 2nd. TD Cowen raised shares of Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $365.00 target price on shares of Cigna Group in a research note on Tuesday, August 26th. Finally, Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Cigna Group has a consensus rating of "Buy" and an average price target of $374.76.

Cigna Group Price Performance

Cigna Group stock traded down $2.74 during mid-day trading on Tuesday, reaching $294.40. 592,897 shares of the company were exchanged, compared to its average volume of 1,804,309. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. Cigna Group has a 12 month low of $256.89 and a 12 month high of $366.91. The firm has a market cap of $78.58 billion, a PE ratio of 16.07, a PEG ratio of 0.89 and a beta of 0.48. The company has a fifty day simple moving average of $295.15 and a 200-day simple moving average of $312.02.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. The firm had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company's revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th will be given a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, September 4th. Cigna Group's dividend payout ratio is presently 32.97%.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the company's stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares of the company's stock, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.70% of the stock is owned by insiders.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.